BARDA funding would be great but don't expect a large amount if approved. The list of companies trying to score is long and some well ahead of GNBT. S1 still not approved, listing has nothing to do with BARDA, we should have been listed by now. Institutional buying would help to boost the pps pending BARDA and only increase if funded. It doesn't help when Discover/Auctus funding (S1) are in litigation with the company or did they settle for now?? Integrity, trust and soon competence will decide the direction and success of the company................
The world is slowly returning to a "new" normal and a vaccine or antibody will soon be another flu medicine available anywhere. Of course we still have an unlocked list of value just in case our Covid is unsuccessful.